公开(公告)号：US20110150986A1

公开(公告)日：2011-06-23

申请号：US12731315

申请日：2010-03-25

Applicant: Kristin Arnold ,  Matthew W. Davis ,  Suman Wason ,  Siva Rama K. Nutalapati

Inventor： Kristin Arnold ,  Matthew W. Davis ,  Suman Wason ,  Siva Rama K. Nutalapati

IPC: A61K9/48 ,  A61K9/00 ,  A61K9/36 ,  A61K31/439

CPC classification number: A61K9/2072 ,  A61K9/2886 ,  A61K31/439 ,  A61K31/4709 ,  Y02A50/411

Abstract: Disclosed herein are quinine formulations and methods of using quinine formulations. Specifically disclosed herein are solid oral dosage forms which can be administered as a capsule or tablet, or alternatively as a sprinkle form with the patient experiencing little or no bitter taste. The dosage forms provide immediate release in vitro and in vivo.

Abstract translation: 本文公开了奎宁配方和使用奎宁制剂的方法。 本文具体公开的是固体口服剂型，其可以作为胶囊或片剂施用，或作为喷洒形式施用，患者经历很少或没有苦味。 剂型在体外和体内提供即时释放。

公开(公告)号：US20110150992A1

公开(公告)日：2011-06-23

申请号：US12971051

申请日：2010-12-17

Applicant: Kristin Arnold ,  Matthew W. Davis ,  Suman Wason ,  Siva Rama K. Nutalapati

Inventor： Kristin Arnold ,  Matthew W. Davis ,  Suman Wason ,  Siva Rama K. Nutalapati

IPC: A61K9/48 ,  A61K31/439 ,  A61K9/30 ,  A61K9/36 ,  A61K9/32 ,  A61P33/06

CPC classification number: A61K9/2072 ,  A61K9/2886 ,  A61K31/439 ,  A61K31/4709 ,  Y02A50/411

Abstract: Disclosed herein are quinine formulations and methods of using quinine formulations. Specifically disclosed herein are solid oral dosage forms which can be administered as a capsule or tablet, or alternatively as a sprinkle form with the patient experiencing little or no bitter taste. The dosage forms provide immediate release in vitro and in vivo.

Abstract translation: 本文公开了奎宁配方和使用奎宁制剂的方法。 本文具体公开的是固体口服剂型，其可以作为胶囊或片剂施用，或作为喷洒形式施用，患者经历很少或没有苦味。 剂型在体外和体内提供即时释放。

公开(公告)号：US20120183605A1

公开(公告)日：2012-07-19

申请号：US13232581

申请日：2011-09-14

Applicant: Kristin Arnold ,  Matthew W. Davis ,  Suman Wason ,  Siva Rama K. Nutalapati

Inventor： Kristin Arnold ,  Matthew W. Davis ,  Suman Wason ,  Siva Rama K. Nutalapati

IPC: A61K9/48 ,  A61K31/439 ,  A61P33/00 ,  A61K9/00

CPC classification number: A61K9/2072 ,  A61K9/2846 ,  A61K31/439 ,  A61K31/4709 ,  A61K31/49 ,  Y02A50/411

Abstract: Disclosed herein are quinine formulations and methods of using quinine formulations. Specifically disclosed herein are solid oral dosage forms which can be administered as a capsule or tablet, or alternatively as a sprinkle form with the patient experiencing little or no bitter taste. The dosage forms provide immediate release in vitro and in vivo.

Abstract translation: 本文公开了奎宁配方和使用奎宁制剂的方法。 本文具体公开的是固体口服剂型，其可以作为胶囊或片剂施用，或作为喷洒形式施用，患者经历很少或没有苦味。 剂型在体外和体内提供即时释放。